Dr. Nguyen joins Bruker’s Kate Stumpo for a wide-ranging conversation on her experiences in the field of omics.
Dr. Nguyen joins Bruker’s Kate Stumpo for a wide-ranging conversation on her experiences in the field of omics.
Sapient’s Dr. Mo Jain discusses the role next-generation mass spectrometry will play in the evolution of precision drug development.
See how we deliver bespoke services for metabolomics, lipidomics, and proteomics data generation and analysis.
See how our methods enable deep coverage of the blood & tissue proteome, and are scalable to your throughput needs.
Population health studies finally have an efficient, scalable approach to ‘go beyond the genome’ in biomarker discovery.
Dr. Jain shares how nontargeted biomarker discovery provides a nontraditional path to advance drug development.
Why data transparency is imperative to ensure the accuracy and reproducibility of findings that inform drug development.
10421 Wateridge Circle, Suite 100
San Diego, CA 92121
discover@sapient.bio
858.290.7010
© 2024 Sapient Bioanalytics, LLC. All rights reserved.
SAPIENT, the SAPIENT Logo, ACCELERATE HUMAN DISCOVERY, and SPECIFICITY AT SCALE are trademarks of Sapient Bioanalytics, LLC
